[The role of DNA methylation in the screening of endometrial cancer in postmenopausal women].

To explore the application value of cervical exfoliated cell DNA methylation (CDO1 and CELF4) combined with or without transvaginal sonography (TVS) for screening endometrial cancer in postmenopausal women. A total of 143 postmenopausal women who underwent hysteroscopy for suspected endometrial lesions in the Department of Obstetrics and Gynecology of Peking Union Medical College Hospital from May 2020 to October 2021 were enrolled in this study. The cervical exfoliated cells were collected for gene methylation before hysteroscopy. Clinical information, tumor biomarkers, and endometrial thickness of TVS were also collected. With endometrial histopathology as the gold standard, multivariate unconditional logistic regression was applied to analyze the risk factors of endometrial cancer. The role of gene methylation with or without TVS were specifically explored. The 143 patients were divided into an endometrial cancer group (=56) and a control group (=87), aged (59.27±6.45) and (61.07±8.26) years, respectively (=0.051). Multivariate logistic regression analysis showed that, CA125≥35 U/ml, postmenopausal bleeding, endometrial thickness≥5 mm, CDO1 ΔCt≤8.4, and CELF4 ΔCt≤8.8 were the risk factors for endometrial cancer, with (95%) of 33.23 (2.51-1 335.28), 8.41(1.81-39.05), 14.45 (2.35-88.84), 17.34 (3.34-89.98), and 44.01 (6.79-285.25), respectively (all values0.05). The sensitivity and specificity of dual-gene methylation (CDO1 or CELF4) in the screening of endometrial carcinoma were both higher than others factors, reaching 87.5% (95%: 75.9%-94.8%) and 90.8% (95%: 82.7%-95.9%), respectively. TVS combined with DNA methylation detection further improved the sensitivity to 100.0% (95%: 93.6%-100.0%), but could not improve the specificity (59.8%, 95%: 48.8%-70.1%). In postmenopausal women with suspected endometrial lesions, the accuracy of cervical cytology DNA methylation is better than other noninvasive clinical indicators for the screening of endometrial cancer. DNA methylation combined with TVS can further improve the sensitivity of screening.